Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

34.48
Delayed Data
As of 4:00pm ET
 -0.03 / -0.09%
Today’s Change
15.15
Today|||52-Week Range
34.86
+106.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues778.2M723.1M753.8M771.4M
 
 
 
 
 
Cost of Goods Sold95.4M122.4M130.6M122.9M
 
 
 
 
 
Depreciation And Amortization13.8M25.0M26.7M48.3M
 
 
 
 
 
 
Operating ExpensesGross Income669.0M575.7M596.5M600.2M
 
 
 
 
 
General Expenses394.6M441.5M429.7M516.2M
 
 
 
 
 
Research And Development67.5M75.5M70.6M74.4M
 
 
 
 
 
Total Operating Expenses503.8M588.9M587.0M687.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income274.4M134.2M166.8M84.0M
 
 
 
 
 
Extraordinary Credit0.00--0.00800.0K
 
 
Extraordinary Charge0.00--0.00-38.3M
 
 
Interest Expense On Debt--0.000.006.0M
 
 
Other Expenses-2.0M300.0K1.2M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income277.9M134.9M168.9M42.9M
 
 
 
 
 
Income Taxes-101.6M-54.7M-43.6M-21.3M
 
 
 
 
 
Minority Interest0.000.000.00-200.0K
 
 
Net Income176.2M80.2M125.3M21.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.7M71.3M70.0M68.3M
 
 
 
 
 
Shares To Calculate EPS Diluted78.2M74.5M73.4M68.8M
 
 
 
 
 
 
Earnings Per ShareEPS$2.25$1.08$1.71$0.32
 
 
 
 
 
EPS Diluted$2.25$1.08$1.71$0.32